Literature DB >> 22817694

Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.

Huayun Chen1, Kun Suo, Yang Cheng, Bin Zheng, Lixin Xu.   

Abstract

Vascular endothelial growth factor C (VEGF-C) is correlated positively with clinical cervical cancer metastasis and survival. Previously we showed that VEGF-C directly activated actin-binding protein moesin, leading to the formation of membrane protrusions. However, whether VEGF-C alters cervical cancer cell adhesion to the extra-cellular matrix is currently unknown. In this study, we investigated the effects of VEGF-C on the formation of focal adhesion complexes, which provide anchoring sites for cell attachment to the extracellular matrix. On cultured cervical carcinoma cell line SiHa cells, VEGF-C enhanced focal adhesion kinase (FAK) phosphorylation. As a result, VEGF-C led to increased formation of focal adhesion complexes and enhanced migration and invasion, which was reversed by siRNA abrogating FAK. VEGF-C resulted in increased interaction of its receptor Flt-4 with non-receptor tyrosine kinase c-Src, leading to c-Src phosphorylation. The specific inhibitor of c-Src kinase, PP2, or the transfection with specific c-Src siRNA largely impaired VEGF-C-enhanced FAK phosphorylation, suggesting that Flt-4/c-Src cascade plays a central role in these processes. These results implied that VEGF-C promotes cervical cancer metastasis by activation of FAK protein through Flt-4/c-Src pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817694     DOI: 10.3109/09513590.2012.705387

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

Review 1.  The non-canonical role of vascular endothelial growth factor-C axis in cancer progression.

Authors:  Chu-An Wang; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-16

2.  miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.

Authors:  Pingping Tao; Hao Wen; Binlie Yang; Ai Zhang; Xiaohua Wu; Qing Li
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

3.  Chemokine releasing particle implants for trapping circulating prostate cancer cells.

Authors:  YiHui Huang; Amirhossein Hakamivala; Shuxin Li; Ashwin Nair; Ramesh Saxena; Jer-Tsong Hsieh; Liping Tang
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.